Blanchard Cheryl R
Insider CIK 1326530 · ZMH Sr. VP, Chief Scientific Off. · STIM Director · DARE Director · SPNE Director · VIGL Director · XLO Director · ANIK President, CEO, Director, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2026-04-15 | 2026-04-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2026-03-15 | 2026-03-17 | 25,131 | — | $0 | 25,132 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2026-03-15 | 2026-03-17 | 25,131 | — | $0 | 270,892 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2026-03-15 | 2026-03-17 | 12,104 | $14.20 | $171.9K | 258,788 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2026-03-14 | 2026-03-17 | 24,519 | — | $0 | 49,040 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2026-03-14 | 2026-03-17 | 14,728 | $14.20 | $209.1K | 245,761 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award | 2026-03-14 | 2026-03-17 | 24,520 | — | $0 | 260,489 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2026-03-14 | 2026-03-17 | 24,519 | — | $0 | 235,969 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2026-03-09 | 2026-03-11 | 20,001 | — | $0 | 0 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2026-03-09 | 2026-03-11 | 20,001 | — | $0 | 217,321 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2026-03-09 | 2026-03-11 | 5,871 | $14.96 | $87.8K | 211,450 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 24,761 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 36,690 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 5,017 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 13,928 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 18,068 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 6,432 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 12,155 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2025-08-05 | 2025-08-05 | 24,984 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer | 2025-08-05 | 2025-08-05 | 5,000 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award | 2025-05-22 | 2025-05-23 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2025-03-17 | 2025-03-18 | 25,132 | — | $0 | 50,263 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2025-03-17 | 2025-03-18 | 12,152 | $15.91 | $193.3K | 197,320 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2025-03-17 | 2025-03-18 | 25,132 | — | $0 | 209,472 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2025-03-14 | 2025-03-18 | 71,403 | — | $0 | 71,403 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2025-03-14 | 2025-03-18 | 73,559 | — | $0 | 73,559 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2025-03-11 | 2025-03-13 | 30,060 | — | $0 | 0 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2025-03-11 | 2025-03-13 | 30,060 | — | $0 | 197,015 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2025-03-11 | 2025-03-13 | 12,675 | $16.79 | $212.8K | 184,340 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2025-03-10 | 2025-03-11 | 20,002 | — | $0 | 20,001 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2025-03-10 | 2025-03-11 | 20,002 | — | $0 | 172,826 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2025-03-10 | 2025-03-11 | 5,871 | $16.62 | $97.6K | 166,955 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 18,068 | — | $0 | 18,068 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 5,017 | $9.63 | $48.3K | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 5,017 | — | $0 | 5,017 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 12,155 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 12,155 | — | $0 | 12,155 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 6,432 | $7.62 | $49.0K | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 6,432 | — | $0 | 6,432 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer deriv | 2024-05-03 | 2024-05-07 | 13,928 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-05-03 | 2024-05-07 | 13,928 | — | $0 | 13,928 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 182,699 | — | $0 | 182,699 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2024-03-15 | 2024-03-19 | 75,395 | — | $0 | 75,395 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2024-03-11 | 2024-03-12 | 30,059 | — | $0 | 30,060 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2024-03-11 | 2024-03-12 | 20,001 | — | $0 | 40,003 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2024-03-11 | 2024-03-12 | 14,420 | — | $0 | 0 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2024-03-11 | 2024-03-12 | 14,534 | $25.79 | $374.8K | 151,694 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2024-03-11 | 2024-03-12 | 30,059 | — | $0 | 166,228 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2024-03-11 | 2024-03-12 | 6,973 | $25.42 | $177.3K | 122,641 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2024-03-11 | 2024-03-12 | 20,001 | — | $0 | 142,642 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2024-03-11 | 2024-03-12 | 14,420 | — | $0 | 129,614 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2024-03-11 | 2024-03-12 | 6,473 | $25.42 | $164.5K | 136,169 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2024-03-01 | 2024-03-05 | 24,761 | — | $0 | 24,761 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2023-06-21 | 2023-06-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 13,928 | — | $0 | 13,928 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2023-04-26 | 2023-04-28 | 24,575 | — | $0 | 0 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2023-04-26 | 2023-04-28 | 10,900 | $26.34 | $287.1K | 114,255 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2023-04-26 | 2023-04-28 | 24,575 | — | $0 | 125,155 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2023-03-10 | 2023-03-14 | 30,060 | — | $0 | 60,119 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2023-03-10 | 2023-03-14 | 30,060 | — | $0 | 113,791 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2023-03-10 | 2023-03-14 | 13,211 | $26.10 | $344.8K | 100,580 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2023-03-09 | 2023-03-10 | 130,998 | — | $0 | 130,998 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2023-03-09 | 2023-03-10 | 60,004 | — | $0 | 60,004 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2023-03-09 | 2023-03-10 | 14,419 | — | $0 | 14,420 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2023-03-09 | 2023-03-10 | 14,419 | — | $0 | 87,963 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2023-03-09 | 2023-03-10 | 4,232 | $26.91 | $113.9K | 83,731 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 6,432 | $7.62 | $49.0K | 6,432 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2022-06-23 | 2022-06-24 | 38,000 | — | $0 | 38,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2022-06-09 | 2022-06-13 | 12,155 | — | $0 | 12,155 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2022-04-26 | 2022-04-28 | 24,576 | — | $0 | 24,575 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2022-04-26 | 2022-04-28 | 24,576 | — | $0 | 72,826 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2022-03-11 | 2022-03-15 | 208,821 | — | $0 | 208,821 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2022-03-11 | 2022-03-15 | 90,179 | — | $0 | 90,179 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | P Buy | 2022-03-11 | 2022-03-14 | 3,813 | $25.81 | $98.4K | 59,992 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | P Buy | 2022-03-11 | 2022-03-14 | 4,287 | $25.36 | $108.7K | 56,179 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2022-03-09 | 2022-03-11 | 14,420 | — | $0 | 28,839 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2022-03-09 | 2022-03-11 | 14,420 | — | $0 | 51,892 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 5,017 | $9.63 | $48.3K | 5,017 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2021-06-24 | 2021-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2021-06-15 | 2021-06-17 | 2,994 | — | $0 | 101,644 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2021-06-15 | 2021-06-17 | 2,994 | $33.40 | $100.0K | 37,472 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2021-04-26 | 2021-04-28 | 24,575 | — | $0 | 49,151 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2021-04-26 | 2021-04-28 | 24,575 | — | $0 | 34,478 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2021-03-09 | 2021-03-11 | 43,259 | — | $0 | 43,259 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2021-03-09 | 2021-03-11 | 108,398 | — | $0 | 108,398 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2020-06-25 | 2020-06-26 | 22,500 | — | $0 | 22,500 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2020-05-26 | 2020-05-28 | 30,000 | — | $0 | 34,437 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2020-04-26 | 2020-04-28 | 104,638 | — | $0 | 104,638 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2020-04-26 | 2020-04-28 | 73,726 | — | $0 | 73,726 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2020-04-26 | 2020-04-28 | 1,794 | $33.40 | $59.9K | 9,903 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2020-04-26 | 2020-04-28 | 4,231 | — | $0 | 11,697 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 4,231 | — | $0 | 4,231 | SEC↗ |
| DARE Dare Bioscience, Inc. | A Award deriv | 2019-11-20 | 2019-11-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| STIM Neuronetics, Inc. | A Award deriv | 2019-05-28 | 2019-05-30 | 7,347 | — | $0 | 7,347 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2019-05-28 | 2019-05-30 | 3,723 | — | $0 | 4,437 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award | 2019-02-26 | 2019-02-28 | 3,842 | — | $0 | 7,466 | SEC↗ |
| STIM Neuronetics, Inc. | A Award deriv | 2019-02-13 | 2019-02-15 | 1,453 | — | $0 | 1,453 | SEC↗ |
| STIM Neuronetics, Inc. | A Award | 2019-02-13 | 2019-02-15 | 714 | — | $0 | 714 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award | 2018-08-31 | 2018-09-05 | 3,624 | — | $0 | 3,624 | SEC↗ |
| SPNE SeaSpine Holdings Corp | A Award | 2018-05-30 | 2018-05-31 | 8,857 | — | $0 | 28,948 | SEC↗ |
| SPNE SeaSpine Holdings Corp | A Award | 2017-06-14 | 2017-06-15 | 10,081 | — | $0 | 20,091 | SEC↗ |
| SPNE SeaSpine Holdings Corp | A Award | 2016-06-07 | 2016-06-09 | 10,010 | — | $0 | 10,010 | SEC↗ |
| SPNE SeaSpine Holdings Corp | A Award deriv | 2015-08-01 | 2015-08-04 | 54,054 | — | $0 | 54,054 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2012-03-19 | 2012-03-21 | 32,320 | — | $0 | 32,320 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | M Exercise deriv | 2012-03-16 | 2012-03-20 | 4,368 | — | $0 | 8,736 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | M Exercise | 2012-03-16 | 2012-03-20 | 4,368 | — | $0 | 19,705 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | F Tax w/h | 2012-03-16 | 2012-03-20 | 1,348 | $63.94 | $86.2K | 18,357 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | A Award deriv | 2012-02-21 | 2012-02-23 | 11,234 | — | $0 | 11,234 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | M Exercise deriv | 2012-02-17 | 2012-02-22 | 2,794 | — | $0 | 2,793 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | F Tax w/h | 2012-02-17 | 2012-02-22 | 862 | $61.66 | $53.2K | 15,337 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | M Exercise | 2012-02-17 | 2012-02-22 | 2,794 | — | $0 | 16,199 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | M Exercise deriv | 2012-01-10 | 2012-01-11 | 12,000 | — | $0 | 0 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | S Sale | 2012-01-10 | 2012-01-11 | 12,000 | $55.00 | $660.0K | 13,270 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | M Exercise | 2012-01-10 | 2012-01-11 | 12,000 | $39.53 | $474.4K | 25,270 | SEC↗ |
| ZMH ZIMMER HOLDINGS INC | F Tax w/h | 2011-02-17 | 2012-01-11 | 862 | $61.55 | $53.1K | 13,155 | SEC↗ |